as on October 31, 2025 at 1:29 am IST
Day's Low
Day's High

0.16%
Downside
4.32%
Upside

52 Week's Low
52 Week's High

18.30%
Downside
18.34%
Upside

Check Alkermes Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.1B
EPS (TTM)
1.9503
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.12%
PE Ratio (TTM)
15.33
Industry PE ratio
8.355964912280701
PEG Ratio
-1057.29
EBITDA
388.7M
Revenue (TTM)
1.5B
Profit Margin
22.27%
Return On Equity TTM
22.35%
Track how Alkermes Plc P/E has moved over time to understand its valuation trends.
Alkermes Plc in the last 5 years
Lowest (9.88x)
December 31, 2024
Industry (8.36x)
October 31, 2025
Today (15.33x)
October 31, 2025
Highest (118.46x)
March 31, 2023
Today’s Price to Earnings Ratio: 15.33x
Compare market cap, revenue, PE, and other key metrics of Alkermes Plc with its industry peers.
| Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | 
|---|---|---|---|---|---|
| BUY | $5.1B | 89.66% | 15.33 | 22.27% | |
| BUY | $20.5B | NA | 17.21 | 40.65% | |
| BUY | $40.8B | NA | 20.11 | 13.81% | |
| BUY | $13.8B | 39.9% | 33.02 | 15.95% | |
| BUY | $63.9B | -9.11% | 24.76 | 27.83% | 
The Alkermes Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Alkermes Plc investment value today
Current value as on today
₹1,25,511
Returns
₹25,511
(+25.51%)
Returns from Alkermes Plc Stock
₹19,844 (+19.84%)
Dollar Returns*
₹5,667 (+5.67%)
Based on 19 analysts
63.16%
Buy
31.58%
Hold
5.26%
Sell
Based on 19 analysts, 63.16% of analysts recommend a 'BUY' rating for Alkermes Plc. Average target price of $44
Get share price movements and forecasts by analysts on Alkermes Plc.
What analysts predicted
30%UPSIDE
Target Price
$44
Current Price
$30.8
Analyzed by
19 Analysts
Target
$44.00
Alkermes Plc target price $44, a slight upside of 30% compared to current price of $30.8. According to 19 analysts rating.
Search interest for Alkermes Plc Stock has increased by 110% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:110% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD

Today's Timeline - 26 September
Fri, 10:22 PM
-Alkermes stock rises 5% after RBC upgrades to outperform and raises price target to $44.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
 POSITIVE IMPACT
POSITIVE IMPACTPrice Rise

In the last 7 days, ALKS stock has moved up by 3.4%
 POSITIVE IMPACT
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 3 quarters, 306.51M → 394.18M (in $), with an average increase of 11.2% per quarter
 NO EFFECT
NO EFFECTAgainst Peers

In the last 1 year, United Therapeutics Corporation has given 21.3% return, outperforming this stock by 1.4%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 3 years, United Therapeutics Corporation has given 96.7% return, outperforming this stock by 60.9%
 NEGATIVE IMPACT
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 2 quarters, 87.09M → 82.76M (in $), with an average decrease of 5.0% per quarter
| Organisation | Alkermes Plc | 
| Headquarters | Connaught House, Dublin, Ireland, D04 C5Y6 | 
| Industry | Health Technology | 
| CEO | Mr. Richard F. Pops | 
| E-voting on shares | Click here to vote | 
| Name | Title | 
|---|---|
| Mr. Christian Todd Nichols | Senior VP & Chief Commercial Officer | 
| Mr. Joshua Reed M.B.A. | Chief Financial Officer | 
| Mr. Samuel J. Parisi | Interim Principal Accounting Officer & VP of Finance | 
| Mr. Thomas Harvey | Chief Information Officer & Senior VP of IT | 
| Ms. Sandra Coombs | Senior Vice President of Corporate Affairs & Investor Relations | 
| Mr. Blair C. Jackson | Executive VP, Chief Risk Officer & COO | 
| Mr. David Joseph Gaffin J.D. | Executive VP, Chief Legal Officer, Chief Compliance Officer & Secretary | 
| Dr. Craig C. Hopkinson M.D. | Executive VP of Research & Development and Chief Medical Officer | 
| Mr. Richard F. Pops | Chairman & CEO | 
| Mr. Stephen Schiavo | Senior VP & Chief Human Resources Officer | 
Alkermes Plc share price today is $30.8 as on at the close of the market. Alkermes Plc share today touched a day high of $32.13 and a low of $30.75.
Alkermes Plc share touched a 52 week high of $36.45 on and a 52 week low of $25.17 on . Alkermes Plc stock price today i.e. is closed at $30.8,which is 15.50% down from its 52 week high and 22.39% up from its 52 week low.
Alkermes Plc market capitalisation is $0.01T as on .
Indian investors can start investing in Alkermes Plc (ALKS) shares with as little as ₹88.686 or $1 (as of ) using the INDmoney app. 
      
      For example: If you want to invest $10 or ₹886.86 in Alkermes Plc stock (as per the Rupee-Dollar exchange rate as on ). 
        Based on Alkermes Plc share’s latest price of $30.8 as on October 31, 2025 at 1:29 am IST, you will get 0.3247 shares of Alkermes Plc. Learn more about
          
            fractional shares .
        
Alkermes Plc stock has given 89.66% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
        
 Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?